High-observation protocol cuts length of stay in head, neck CA

July 7, 2017

(HealthDay)—A high-observation protocol (HOP) appears to optimize clinical care for patients with head and neck cancer undergoing primary surgery, according to a study published online June 20 in Head & Neck.

Brittany Barber, M.D., from the University of Alberta in Edmonton, Canada, and colleagues compared patients with head and undergoing primary surgery on the high-observation protocol (52 patients) to a historical cohort (96 patients). Differences in length of (ICU) admission, ICU readmissions, and length of stay were measured.

The researchers found that the HOP clinical pathway was associated with significantly decreased length of ICU admission (1.9 versus 1.2 days; P = 0.021), length of stay (20.3 versus 14.1 days; P = 0.020), and ICU readmissions (10.4 versus 1.9 percent; P = 0.013).

"Rapid weaning of sedation and limiting mechanical ventilation may contribute to a shorter length of ICU admission and length of stay, as well as decreased ICU readmissions," the authors write.

Explore further: 30-day unplanned readmit rate low but costly in head, neck Sx

More information: Abstract
Full Text (subscription or payment may be required)

Related Stories

30-day unplanned readmit rate low but costly in head, neck Sx

April 22, 2015
(HealthDay)—For patients undergoing head and neck surgery, 30-day unplanned readmission rates are low, but costly, according to a review published online March 9 in Head & Neck.

Surgical glue reinforcement OK for lap sleeve gastrectomy

March 27, 2017
(HealthDay)—Surgical glue is safe and cost-effective, compared to standard stapling, during laparoscopic sleeve gastrectomy, according to a study published online March 21 in the Journal of Evaluation in Clinical Practice.

Shorter length of stay tied to earlier readmission for seniors

March 17, 2017
(HealthDay)—For older patients discharged from the hospital to post-acute care (PAC) facilities, shorter length of hospital stay is associated with earlier readmission, according to a study published online March 3 in the ...

ASCO: alvimopan helpful for men undergoing testicular CA surgery

February 17, 2017
(HealthDay)—For men with testicular cancer undergoing retroperitoneal lymph node dissection (RPLND), alvimopan may reduce hospital length of stay (LOS) and enhance gastrointestinal recovery, according to a study presented ...

Reduced cancer-independent life expectancy in head, neck cancer

June 27, 2017
(HealthDay)—Patients with head and neck cancer have reduced life expectancy, independent of cancer, according to a study published online June 22 in Head & Neck.

More side effects with CRT plus metformin in head, neck cancer

May 7, 2017
(HealthDay)—Patients with advanced head and neck cancer undergoing chemoradiotherapy (CRT) and receiving metformin experience more side effects than patients not on metformin, according to research published online April ...

Recommended for you

Research suggests new pathways for hyperaldosteronism

December 7, 2017
A new study led by researchers at Sanford Burnham Prebys Medical Discovery Institute (SBP), in collaboration with researchers at Eunice Kennedy Shriver National Institute of Child Health and Human Development, part of the ...

One-dose gene therapy produces clotting factor, safely stops bleeding in hemophilia B patients

December 6, 2017
A team of gene therapy researchers has reported positive results in a phase 1/2 clinical trial for the inherited bleeding disorder hemophilia B. A single intravenous infusion of a novel bioengineered gene therapy treatment ...

Clot-busting drugs not recommended for most patients with blood clots

December 6, 2017
Not all patients with blood clots in their legs - a condition known as deep vein thrombosis - need to receive powerful but risky clot-busting drugs, according to results of a large-scale, multicenter clinical trial.

Mitochondrial protein in cardiac muscle cells linked to heart failure, study finds

December 5, 2017
Reducing a protein found in the mitochondria of cardiac muscle cells initiates cardiac dysfunction and heart failure, a finding that could provide insight for new treatments for cardiovascular diseases, a study led by Georgia ...

Blood pressure declines 14 to 18 years before death

December 4, 2017
Blood pressure in the elderly gradually begins to decrease about 14 or so years before death, according to a new study published today in the JAMA Internal Medicine.

Study links common male medical condition and vascular disease

December 1, 2017
Men who suffer symptoms from varicoceles, enlarged veins in the scrotum, are more likely to develop vascular disease and metabolic disease, such as diabetes, according to a study by Stanford University School of Medicine ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.